137 related articles for article (PubMed ID: 23446734)
21. The Y49H cytochrome c variant enhances megakaryocytic maturation of K-562 cells.
Shafaei Pishabad Z; Ledgerwood EC
Biochim Biophys Acta Mol Basis Dis; 2024 Jun; 1870(5):167134. PubMed ID: 38531481
[TBL] [Abstract][Full Text] [Related]
22. Division of labor in the growth cone by DSCR1.
Catlett TS; Gomez TM
J Cell Biol; 2016 May; 213(4):407-9. PubMed ID: 27216257
[TBL] [Abstract][Full Text] [Related]
23. Tumor vessel normalization after aerobic exercise enhances chemotherapeutic efficacy.
Schadler KL; Thomas NJ; Galie PA; Bhang DH; Roby KC; Addai P; Till JE; Sturgeon K; Zaslavsky A; Chen CS; Ryeom S
Oncotarget; 2016 Oct; 7(40):65429-65440. PubMed ID: 27589843
[TBL] [Abstract][Full Text] [Related]
24. Regulator of Calcineurin (RCAN): Beyond Down Syndrome Critical Region.
Lee SK; Ahnn J
Mol Cells; 2020 Aug; 43(8):671-685. PubMed ID: 32576715
[TBL] [Abstract][Full Text] [Related]
25. Calcium and calcineurin-NFAT signaling regulate granulocyte-monocyte progenitor cell cycle via Flt3-L.
Fric J; Lim CX; Mertes A; Lee BT; Viganò E; Chen J; Zolezzi F; Poidinger M; Larbi A; Strobl H; Zelante T; Ricciardi-Castagnoli P
Stem Cells; 2014 Dec; 32(12):3232-44. PubMed ID: 25100642
[TBL] [Abstract][Full Text] [Related]
26. Cyclosporin A promotes tumor angiogenesis in a calcineurin-independent manner by increasing mitochondrial reactive oxygen species.
Zhou AY; Ryeom S
Mol Cancer Res; 2014 Nov; 12(11):1663-76. PubMed ID: 25009293
[TBL] [Abstract][Full Text] [Related]
27. Immunosurveillance by antiangiogenesis: tumor growth arrest by T cell-derived thrombospondin-1.
Schadler KL; Crosby EJ; Zhou AY; Bhang DH; Braunstein L; Baek KH; Crawford D; Crawford A; Angelosanto J; Wherry EJ; Ryeom S
Cancer Res; 2014 Apr; 74(8):2171-81. PubMed ID: 24590059
[TBL] [Abstract][Full Text] [Related]
28. Integrated genomic analysis illustrates the central role of JAK-STAT pathway activation in myeloproliferative neoplasm pathogenesis.
Rampal R; Al-Shahrour F; Abdel-Wahab O; Patel JP; Brunel JP; Mermel CH; Bass AJ; Pretz J; Ahn J; Hricik T; Kilpivaara O; Wadleigh M; Busque L; Gilliland DG; Golub TR; Ebert BL; Levine RL
Blood; 2014 May; 123(22):e123-33. PubMed ID: 24740812
[TBL] [Abstract][Full Text] [Related]
29. Somatic mutations of calreticulin in myeloproliferative neoplasms.
Klampfl T; Gisslinger H; Harutyunyan AS; Nivarthi H; Rumi E; Milosevic JD; Them NC; Berg T; Gisslinger B; Pietra D; Chen D; Vladimer GI; Bagienski K; Milanesi C; Casetti IC; Sant'Antonio E; Ferretti V; Elena C; Schischlik F; Cleary C; Six M; Schalling M; Schönegger A; Bock C; Malcovati L; Pascutto C; Superti-Furga G; Cazzola M; Kralovics R
N Engl J Med; 2013 Dec; 369(25):2379-90. PubMed ID: 24325356
[TBL] [Abstract][Full Text] [Related]
30. An overview on CALR and CSF3R mutations and a proposal for revision of WHO diagnostic criteria for myeloproliferative neoplasms.
Tefferi A; Thiele J; Vannucchi AM; Barbui T
Leukemia; 2014 Jul; 28(7):1407-13. PubMed ID: 24441292
[TBL] [Abstract][Full Text] [Related]
31. Mutated calreticulin retains structurally disordered C terminus that cannot bind Ca(2+): some mechanistic and therapeutic implications.
Shivarov V; Ivanova M; Tiu RV
Blood Cancer J; 2014 Feb; 4(2):e185. PubMed ID: 24562385
[No Abstract] [Full Text] [Related]
32. Thrombospondin-1 mediates oncogenic Ras-induced senescence in premalignant lung tumors.
Baek KH; Bhang D; Zaslavsky A; Wang LC; Vachani A; Kim CF; Albelda SM; Evan GI; Ryeom S
J Clin Invest; 2013 Oct; 123(10):4375-89. PubMed ID: 24018559
[TBL] [Abstract][Full Text] [Related]
33. Genetic variation at MECOM, TERT, JAK2 and HBS1L-MYB predisposes to myeloproliferative neoplasms.
Tapper W; Jones AV; Kralovics R; Harutyunyan AS; Zoi K; Leung W; Godfrey AL; Guglielmelli P; Callaway A; Ward D; Aranaz P; White HE; Waghorn K; Lin F; Chase A; Baxter EJ; Maclean C; Nangalia J; Chen E; Evans P; Short M; Jack A; Wallis L; Oscier D; Duncombe AS; Schuh A; Mead AJ; Griffiths M; Ewing J; Gale RE; Schnittger S; Haferlach T; Stegelmann F; Döhner K; Grallert H; Strauch K; Tanaka T; Bandinelli S; Giannopoulos A; Pieri L; Mannarelli C; Gisslinger H; Barosi G; Cazzola M; Reiter A; Harrison C; Campbell P; Green AR; Vannucchi A; Cross NC
Nat Commun; 2015 Apr; 6():6691. PubMed ID: 25849990
[TBL] [Abstract][Full Text] [Related]
34. Lung stem cell differentiation in mice directed by endothelial cells via a BMP4-NFATc1-thrombospondin-1 axis.
Lee JH; Bhang DH; Beede A; Huang TL; Stripp BR; Bloch KD; Wagers AJ; Tseng YH; Ryeom S; Kim CF
Cell; 2014 Jan; 156(3):440-55. PubMed ID: 24485453
[TBL] [Abstract][Full Text] [Related]
35. Somatic CALR mutations in myeloproliferative neoplasms with nonmutated JAK2.
Nangalia J; Massie CE; Baxter EJ; Nice FL; Gundem G; Wedge DC; Avezov E; Li J; Kollmann K; Kent DG; Aziz A; Godfrey AL; Hinton J; Martincorena I; Van Loo P; Jones AV; Guglielmelli P; Tarpey P; Harding HP; Fitzpatrick JD; Goudie CT; Ortmann CA; Loughran SJ; Raine K; Jones DR; Butler AP; Teague JW; O'Meara S; McLaren S; Bianchi M; Silber Y; Dimitropoulou D; Bloxham D; Mudie L; Maddison M; Robinson B; Keohane C; Maclean C; Hill K; Orchard K; Tauro S; Du MQ; Greaves M; Bowen D; Huntly BJP; Harrison CN; Cross NCP; Ron D; Vannucchi AM; Papaemmanuil E; Campbell PJ; Green AR
N Engl J Med; 2013 Dec; 369(25):2391-2405. PubMed ID: 24325359
[TBL] [Abstract][Full Text] [Related]
36. Transcription factors of the NFAT family: regulation and function.
Rao A; Luo C; Hogan PG
Annu Rev Immunol; 1997; 15():707-47. PubMed ID: 9143705
[TBL] [Abstract][Full Text] [Related]
37. Frequent CALR exon 9 alterations in JAK2 V617F-mutated essential thrombocythemia detected by high-resolution melting analysis.
Lim KH; Chang YC; Gon-Shen Chen C; Lin HC; Wang WT; Chiang YH; Cheng HI; Su NW; Lin J; Chang YF; Chang MC; Hsieh RK; Kuo YY; Chou WC
Blood Cancer J; 2015 Mar; 5(3):e295. PubMed ID: 25794131
[No Abstract] [Full Text] [Related]
38. Calreticulin mutations and long-term survival in essential thrombocythemia.
Tefferi A; Wassie EA; Lasho TL; Finke C; Belachew AA; Ketterling RP; Hanson CA; Pardanani A; Gangat N; Wolanskyj AP
Leukemia; 2014 Dec; 28(12):2300-3. PubMed ID: 24791854
[TBL] [Abstract][Full Text] [Related]
39. Type 1 versus Type 2 calreticulin mutations in essential thrombocythemia: a collaborative study of 1027 patients.
Tefferi A; Wassie EA; Guglielmelli P; Gangat N; Belachew AA; Lasho TL; Finke C; Ketterling RP; Hanson CA; Pardanani A; Wolanskyj AP; Maffioli M; Casalone R; Pacilli A; Vannucchi AM; Passamonti F
Am J Hematol; 2014 Aug; 89(8):E121-4. PubMed ID: 24753125
[TBL] [Abstract][Full Text] [Related]
40. Improved HSC reconstitution and protection from inflammatory stress and chemotherapy in mice lacking granzyme B.
Carnevalli LS; Scognamiglio R; Cabezas-Wallscheid N; Rahmig S; Laurenti E; Masuda K; Jöckel L; Kuck A; Sujer S; Polykratis A; Erlacher M; Pasparakis M; Essers MA; Trumpp A
J Exp Med; 2014 May; 211(5):769-79. PubMed ID: 24752302
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
